300 related articles for article (PubMed ID: 31501268)
1. The Role of PTEN in Innate and Adaptive Immunity.
Taylor H; Laurence ADJ; Uhlig HH
Cold Spring Harb Perspect Med; 2019 Dec; 9(12):. PubMed ID: 31501268
[TBL] [Abstract][Full Text] [Related]
2. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.
Chen HH; Händel N; Ngeow J; Muller J; Hühn M; Yang HT; Heindl M; Berbers RM; Hegazy AN; Kionke J; Yehia L; Sack U; Bläser F; Rensing-Ehl A; Reifenberger J; Keith J; Travis S; Merkenschlager A; Kiess W; Wittekind C; Walker L; Ehl S; Aretz S; Dustin ML; Eng C; Powrie F; Uhlig HH
J Allergy Clin Immunol; 2017 Feb; 139(2):607-620.e15. PubMed ID: 27477328
[TBL] [Abstract][Full Text] [Related]
3. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.
Sloot YJE; Rabold K; Netea MG; Smit JWA; Hoogerbrugge N; Netea-Maier RT
Oncogene; 2019 May; 38(19):3743-3755. PubMed ID: 30670777
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome.
Heindl M; Händel N; Ngeow J; Kionke J; Wittekind C; Kamprad M; Rensing-Ehl A; Ehl S; Reifenberger J; Loddenkemper C; Maul J; Hoffmeister A; Aretz S; Kiess W; Eng C; Uhlig HH
Gastroenterology; 2012 May; 142(5):1093-1096.e6. PubMed ID: 22266152
[TBL] [Abstract][Full Text] [Related]
5. Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice.
Jaini R; Loya MG; King AT; Thacker S; Sarn NB; Yu Q; Stark GR; Eng C
Hum Mol Genet; 2020 Aug; 29(14):2353-2364. PubMed ID: 32588888
[TBL] [Abstract][Full Text] [Related]
6. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.
Sahin E; Haubenwallner S; Kuttke M; Kollmann I; Halfmann A; Dohnal AM; Chen L; Cheng P; Hoesel B; Einwallner E; Brunner J; Kral JB; Schrottmaier WC; Thell K; Saferding V; Blüml S; Schabbauer G
J Immunol; 2014 Aug; 193(4):1717-27. PubMed ID: 25015834
[TBL] [Abstract][Full Text] [Related]
7. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
Ke B; Shen XD; Ji H; Kamo N; Gao F; Freitas MC; Busuttil RW; Kupiec-Weglinski JW
J Hepatol; 2012 Feb; 56(2):359-66. PubMed ID: 21756853
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties.
Günzl P; Schabbauer G
Immunobiology; 2008; 213(9-10):759-65. PubMed ID: 18926291
[TBL] [Abstract][Full Text] [Related]
9. Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome".
Galatola M; Paparo L; Duraturo F; Turano M; Rossi GB; Izzo P; De Rosa M
BMC Med Genet; 2012 Apr; 13():28. PubMed ID: 22520842
[TBL] [Abstract][Full Text] [Related]
10. Regulation of T-cell responses by PTEN.
Buckler JL; Liu X; Turka LA
Immunol Rev; 2008 Aug; 224():239-48. PubMed ID: 18759931
[TBL] [Abstract][Full Text] [Related]
11. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
12. Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells.
Nebe M; Kehr S; Schmitz S; Breitfeld J; Lorenz J; Le Duc D; Stadler PF; Meiler J; Kiess W; Garten A; Kirstein AS
Biochem Biophys Res Commun; 2022 May; 604():57-62. PubMed ID: 35290761
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
14. PTEN hamartoma tumor syndromes.
Blumenthal GM; Dennis PA
Eur J Hum Genet; 2008 Nov; 16(11):1289-300. PubMed ID: 18781191
[TBL] [Abstract][Full Text] [Related]
15. PTEN in Hereditary and Sporadic Cancer.
Ngeow J; Eng C
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31570378
[TBL] [Abstract][Full Text] [Related]
16. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
[TBL] [Abstract][Full Text] [Related]
17. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease.
Torices L; Mingo J; Rodríguez-Escudero I; Fernández-Acero T; Luna S; Nunes-Xavier CE; López JI; Mercadillo F; Currás M; Urioste M; Molina M; Cid VJ; Pulido R
Eur J Hum Genet; 2023 May; 31(5):568-577. PubMed ID: 36543932
[TBL] [Abstract][Full Text] [Related]
19. PTEN-opathies: from biological insights to evidence-based precision medicine.
Yehia L; Ngeow J; Eng C
J Clin Invest; 2019 Feb; 129(2):452-464. PubMed ID: 30614812
[TBL] [Abstract][Full Text] [Related]
20. Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome.
Wang Q; Von T; Bronson R; Ruan M; Mu W; Huang A; Maira SM; Zhao JJ
Genes Dev; 2013 Jul; 27(14):1568-80. PubMed ID: 23873941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
